Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Abbott Laboratories News

    105,27 $ 0,00% +0,00 $
    In : 98,958 € | 01:00:00 Uhr NYSE aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 850103
    ISIN: US0028241000
    US-Symbol: ABT
    Typ: Aktie
    Werbung

    Attraktive Knock-Outs auf Abbott Laboratories

    Typ Hebel Bid / Ask WKN Typ Hebel Bid / Ask WKN
    Call
    		4,9 2,00 € / 2,01 €
    SB0ZKF
    Put
    		4,6 2,15 € / 2,16 €
    SV10XN
    Call
    		10,6 0,93 € / 0,94 €
    SW479T
    Put
    		8,3 1,19 € / 1,20 €
    SU819J
    Den Basisprospekt sowie endgültige Bedingungen und Basisinformationsblätter erhalten Sie bei Klick auf das Dokument-Icon. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
    Alle Knock-Outs auf Abbott Laboratories
    Werbung
    Weiter aufwärts?
    Long Hebel 6,45
    UM0557

    Abbott Laboratories News

    17.04.24 - PR Newswire
    Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
    Abbott Reports First-​Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges PR Newswire
    02.04.24 - PR Newswire
    Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve
    Abbott Receives FDA Approval for TriClip™, First-​of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve PR Newswire
    01.04.24 - PR Newswire
    Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside
    Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside PR Newswire
    27.03.24 - PR Newswire
    Abbott Hosts Conference Call for First-Quarter Earnings
    Abbott Hosts Conference Call for First-​Quarter Earnings PR Newswire
    06.03.24 - PR Newswire
    Real-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes
    Real-​World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes PR Newswire
    16.02.24 - PR Newswire
    Abbott Declares 401st Consecutive Quarterly Dividend
    Abbott Declares 401st Consecutive Quarterly Dividend PR Newswire
    13.02.24 - PR Newswire
    FDA Advisory Committee Votes in Favor of Abbott's First-of-Its-Kind TriClip™ System to Treat People With a Leaky Tricuspid Heart Valve
    FDA Advisory Committee Votes in Favor of Abbott's First-​of-Its-Kind TriClip™ System to Treat People With a Leaky Tricuspid Heart Valve PR Newswire
    01.02.24 - PR Newswire
    New Study Shows Mixed Reality Technology for Blood Donation from Abbott and Blood Centers of America Helps Ease Stress, Encourages People to Donate Again
    New Study Shows Mixed Reality Technology for Blood Donation from Abbott and Blood Centers of America Helps Ease Stress, Encourages People to Donate Again PR Newswire
    31.01.24 - PR Newswire
    Abbott Launches New PROTALITY™ Brand to Support Adults on Their Weight Loss Journey
    Abbott Launches New PROTALITY™ Brand to Support Adults on Their Weight Loss Journey PR Newswire
    25.01.24 - PR Newswire
    Abbott Launches World's Smallest Rechargeable System With Remote Programming Capabilities to Treat Movement Disorders¹+
    Abbott Launches World's Smallest Rechargeable System With Remote Programming Capabilities to Treat Movement Disorders¹+ PR Newswire
    24.01.24 - PR Newswire
    Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook
    Abbott Reports Fourth-​Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook PR Newswire
    24.01.24 - wallstreet:online Zentralredaktion
    Ihre wichtigsten Termine: Zahlen-Updates von: Tesla, SAP, ASML, IBM, AT&T und Abbott Laboratories
    Gut geplant in den Tag. Mit dem w:o-​Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine ...
    18.01.24 - PR Newswire
    Abbott Announces First Global Procedures in a Clinical Trial of its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
    Abbott Announces First Global Procedures in a Clinical Trial of its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms PR Newswire
    03.01.24 - PR Newswire
    Abbott Hosts Conference Call for Fourth-Quarter Earnings
    Abbott Hosts Conference Call for Fourth-​Quarter Earnings PR Newswire
    18.12.23 - PR Newswire
    Abbott to Present at J.P. Morgan Healthcare Conference
    Abbott to Present at J.P. Morgan Healthcare Conference PR Newswire
    15.12.23 - PR Newswire
    Abbott Increases Quarterly Dividend for 52nd Consecutive Year
    Abbott Increases Quarterly Dividend for 52nd Consecutive Year PR Newswire
    14.12.23 - Jochen Staiger
    MedMira Lebenszeichen!: Erfolgreiche FDA Zulassung in den USA für die HIV-Tests!
    So darf es weiter gehen! Die Pharmabranche wird dies nun sehr wachsam verfolgen denn mit einer weiteren Zulassung für Syphilis sowie Erfolgen bei Multiplo und Miriad dürfte ...
    13.11.23 - PR Newswire
    Late-Breaking Data Show an Aspirin-Free Medication Regimen Benefits People with Abbott's HeartMate 3™ Heart Pump
    Late-​Breaking Data Show an Aspirin-​Free Medication Regimen Benefits People with Abbott's HeartMate 3™ Heart Pump PR Newswire
    08.11.23 - PR Newswire
    Participants in Abbott's Food as Medicine Program Showed Clinically Significant Improvements in Managing Diabetes
    Participants in Abbott's Food as Medicine Program Showed Clinically Significant Improvements in Managing Diabetes PR Newswire
    02.11.23 - PR Newswire
    Abbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV
    Abbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-​Causing Types of HPV PR Newswire

    Newssuche

    Videos

    newspaper
    18.04.24
    Technical Trading: Gold mit weiterem Potenzial
    Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »